羟乙基淀粉200/0.5细菌内毒素检查
摘要
目的对羟乙基淀粉200/0.5细菌内毒素的含量检查。方法细菌内毒素检查采用鲎试剂检测革兰阴性菌产生的细菌内毒素含量。结果试药内毒素检查呈阴性。结论此方法对细菌内毒素的检查符合规定。
出处
《蛇志》
2009年第2期140-141,共2页
Journal of Snake
参考文献3
-
1吴翠栓,吴涛.羟乙基淀粉130/0.4的研究进展[J].中国新药杂志,2005,14(8):981-984. 被引量：15
-
2国家药典委员会.国家药品标准工作手册[M].第3版.北京:国家药典委员会出版,1998.68-157.
-
3国家药典委员会.中国药典[M].第2部.北京;化学工业出版社,2005.附录.
二级参考文献29
-
1Treib J, Baron JF, Grauer MT, et al. An international view of hydroxyethyl starches[J]. Intensive Care Meal, 1999,25 (3) : 258 -268.
-
2Jungheinrich C, Sauermann W, Bepperling F, et al. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study[J]. Drugs R D, 2004,5(1) : 1 - 9.
-
3Sander O, Reinhart K, Hellmann AM. Equivalence of hydroxyethyl starch HES 130/0.4 and HES 200/0.5 for perioperative volume replacement in major gynaecological surgery [J]. Acta Anaesthesiol Scand,2003,47(9) : 1151 - 1158.
-
4Treib J, Haass A, Pindur G, ct al. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions,and coagulation[J]. Transfusion, 1996,36(5) :450 - 455.
-
5Treib J, Haass A, Pindur G, et al. HES 200/0.5 is not HES 200/0.5 Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch(HES) on hemorheology, coagulation and elimination kinetics [J].Thromb Hoemost, 1995,74(6) : 1452 - 1456.
-
6Waitzinger J, Bepperling F, Pabst G. et al. Effect of a new hydroxyethyl starch(HES) specification(6% HES 130/0.4) on blood and plasma volumes after bleeding in 12 healthy male volunteers[Jj.Clin Drug Invest, 1999,17 ( 2 ) : 119 - 125.
-
7Waitzinger J, Bepperling F, Pabst G, et al. Pharmacokinetics and tolerability of a new hydroxyethyl starch ( HES ) specification ( 6%HES130/0.4) after single-dose infusion of 6% or 10% solution in heahhy volunteers[J]. Clin Drug Invest, 1998,16(2) : 151 - 160.
-
8Waitzinger J, Bepper]ing F, Pabst G, et al. Hydroxyethy] starch (HES) [ 130/0.41, a new HES specification : pharmaeokineties and safety after multiple infusions of 10% solution in healthy volunteers[J]. Orugs R O ,2003,4(3) : 149 - 157.
-
9Leuschner J, Opitz J, Winkler A, et al. Tissue storage of ^14 C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats[J]. Drugs R D, 2003,4(6) :331 - 338.
-
10Huet R, Siemous W, Hagenaars A, et al. Is hydroxyethyl starch 130/0.4 the optimal starch plasma substitute in adult cardiac surgery [J]. Anesth Analg, 1998,87( 1 ) : SCA1-SCA124.
共引文献14
-
1Seng Boravat,徐在品,赵梦婕,黄豪圣,路美兰,雷林,李思南,王瑶,明东东.羟乙基淀粉130/0.4联合肾上腺素对失血性休克犬心脏功能的影响[J].黑龙江畜牧兽医,2020(21):95-98.
-
2王亚平,邹定全,常业恬.羟乙基淀粉130/0.4对兔内毒素性急性肺损伤的影响[J].临床麻醉学杂志,2007,23(5):412-414. 被引量：7
-
3陈玉皇,唐永林,王希臻.羟乙基淀粉130/0.4氯化钠注射液致荨麻疹[J].药物不良反应杂志,2007,9(4):290-290. 被引量：6
-
4张书华,杜连文.羟乙基淀粉中环氧乙烷残留量检查的方法探究[J].内蒙古石油化工,2008,34(11):30-30.
-
5杜连文,黄志萍,杨淮英,张书华.旋光法测定羟乙基淀粉200/0.5的含量[J].实用药物与临床,2009,12(1):35-35. 被引量：1
-
6宋更申,周丽,孙玉静.顶空气相色谱法测定羟乙基淀粉中有机溶剂残留量[J].中国药业,2010,19(8):31-32. 被引量：1
-
7贺正江.胶体与容量复苏[J].当代医学,2010,16(18):13-14.
-
8姚英政,朱宇,何文铸,陶渊,陈克贵.代血浆用玉米淀粉的品质分析[J].食品与机械,2012,28(1):68-69.
-
9李春梅.羟乙基淀粉的研究和应用现状综述[J].求医问药（下半月刊）,2011,9(11):156-156. 被引量：1
-
10朱宇,姚英政,何文铸,陈克贵.羟乙基淀粉代血浆用玉米淀粉的品质分析[J].西南农业学报,2012,25(4):1519-1521.
-
1杜连文,黄志萍,杨淮英,张书华.旋光法测定羟乙基淀粉200/0.5的含量[J].实用药物与临床,2009,12(1):35-35. 被引量：1
-
2刘国中.剖宫产手术联合麻醉中预先输注羟乙基淀粉200/0.5氯化钠的临床意义[J].浙江临床医学,2012,14(8):984-985.
-
3金曼,程春萍,周树美.羟乙基淀粉200/0.5氯化钠注射液细菌内毒素检查的可行性研究[J].药学研究,2013,32(9):521-522. 被引量：1
-
4施建琴,张树梅,陈智娴.右旋糖酐40葡萄糖注射液细菌内毒素检查法的研究[J].交通医学,2001,15(5):578-579.
-
5薛瑞,尚博扬,王静珍,狄天云.苦参素注射液细菌内毒素检查法的实验研究[J].宁夏医学杂志,2006,28(3):199-201. 被引量：2
-
6胥德福,吴春华.注射用奥沙利铂细菌内毒素检查法的实验研究[J].中国科技博览,2012(28):86-86.
-
7王建玲,常选妞,王国庆.巴洛沙星质量标准研究[J].河北师范大学学报（自然科学版）,2013,37(3):276-279.
-
8闫辉,闫凯,李金凤.HPLC法测定曲匹地尔胶囊及片剂中有关物质的含量[J].中国药房,2011,22(21):1990-1992. 被引量：3
-
9徐飞,张志华,李晶玉,艾萍.TOC检测法测定羟乙基淀粉200/0.5残留量[J].齐鲁药事,2012,31(7):410-411. 被引量：1
-
10李振光,于占彩,伍期专,王远臣,姚存姗.氯吡格雷对短暂性脑缺血发作患者血浆溶血磷脂酸含量的影响[J].国外医学（脑血管疾病分册）,2005,13(5):338-340. 被引量：3
